Divis' Laboratories Share Price (DIVISLAB)
Check the latest share price of Divis' Laboratories, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Divis' Laboratories Stock Performance
Get live Divis' Laboratories share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹6,611Day's Price Range₹6,720.552 Week's Low
52 Week's High
₹4,395.352-Week Price Range₹6,766
| Returns % | |
| 1 Month Return | + 7.26 % |
| 3 Month Return | + 17.57 % |
| 1 Year Return | + 45.29 % |
| 3 Year Return | + 89.1 % |
| 5 Year Return | + 185.52 % |
| Market Stats | |
| Previous Close | ₹6,725.00 |
| Open | ₹6,700.00 |
| Volume | 4.31L |
| Upper Circuit | ₹7,397.50 |
| Lower Circuit | ₹6,052.50 |
Divis' Laboratories Fundamentals & Key Indicators
Check Divis' Laboratories market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,76,987.90 Cr
Return on Equity (ROE)
12.04
PE Ratio (TTM)
80.78
Return on capital employed (ROCE)
16.27
Industry PE ratio
57.39
Beta (LTM)
0.75
P/B Ratio
6.75
Dividend Yield
0.87
PEG Ratio
3.63
Quarterly Earnings Growth YOY
23.05
EPS (TTM)
60.38
Sector
Pharmaceuticals
Book Value
512.11
Technical Analysis
Bullish
View Technical Analysis
How to invest in Divis' Laboratories?
Investing in Divis' Laboratories is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Divis' Laboratories or DIVISLAB on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Divis' Laboratories or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Divis' Laboratories with just a few clicks!
Divis' Laboratories Stock's Interest Amongst Investors
Divis' Laboratories Valuation
Track how Divis' Laboratories P/E has moved over time to understand its valuation trends.
Divis' Laboratories in the last 5 years
Lowest (28.97x)
November 21, 2022
Industry (57.39x)
June 13, 2025
Today (80.78x)
June 13, 2025
Highest (90.48x)
December 4, 2024
Today’s Price to Earnings Ratio: 80.78x
Divis' Laboratories Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Divis' Laboratories.
based on 30 analysts
41.38%
Buy
24.14%
Hold
34.48%
Sell
41.38% of analysts recommend a 'HOLD' rating for Divis' Laboratories. Average target price of ₹6364.73
Source: S&P Global Market Intelligence
Divis' Laboratories Share Price Target
Get share price movements and forecasts by analysts on Divis' Laboratories.
Divis' Laboratories price forecast by 30 analysts
Downside of-4.53%
High
₹7750
Target
₹6364.73
Low
₹4381
Divis' Laboratories target price ₹6364.73, a slight downside of -4.53% compared to current price of ₹6667. According to 30 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Divis' Laboratories revenue growth forecast
Expected growth rate Q1, FY2027:65.42%
Forecast
Actual
Including amortisation and stock based compensations
Divis' Laboratories EPS growth forecast
EPS estimate Q1, FY2027:108.66%
Forecast
Actual
Source: S&P Global Market Intelligence
Divis' Laboratories Financial Results
Get the annual and quarterly financial summary of Divis' Laboratories, including revenue, profit, loss and more.
Indices Featuring Divis' Laboratories Stock
Check stock indices that include Divis' Laboratories.
Divis' Laboratories Earnings and Dividends
View detailed summary of the earnings and dividend history of Divis' Laboratories.
Divis Laboratories Ltd Earnings Results
Divis Laboratories Ltd’s net profit jumped 23.05% since last year same period to ₹662Cr in the Q4 2024-2025. On a quarterly growth basis, Divis Laboratories Ltd has generated 12.39% jump in its net profits since last 3-months.
Read More about Earnings ResultsDivis Laboratories Ltd Dividends May,2024
In the quarter ending March 2024, Divis Laboratories Ltd has declared dividend of ₹30 - translating a dividend yield of 0.45%.
Read More about Dividends
Divis' Laboratories Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Divis' Laboratories.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 51.89% | 0.00 | |
| Foreign Institutions | 18.01% | 0.00 | |
| Mutual Funds | 12.83% | 0.00 | |
| Retail Investors | 9.39% | 0.00 | |
| Others | 7.88% | 0.00 |
Divis' Laboratories vs Peers
Compare market cap, revenue, PE, and other key metrics of Divis' Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 1,76,987.90 | 37.1% | 0.50 | 1,600 | 7,845 | |
| BUY | 1,10,074.44 | 32.82% | 0.67 | 1,656 | 10,727 | |
| BUY | 42,669.32 | -1.66% | 0.58 | 1,297 | 14,755 | |
| HOLD | 27,838.89 | -1.43% | 0.50 | 772 | 5,664 | |
| BUY | 1,21,573.55 | 26.77% | 0.50 | 4,155 | 25,774 |
Divis' Laboratories News & Key Events
Latest news and events in one place to help you make informed investing decisions in Divis' Laboratories.
Divis Laboratories Continues Upward Trend - 11 Jun, 2025
Divis Laboratories Ltd is up 1.02% at Rs 6742, marking its third consecutive session of gains. The stock has risen 51.43% over the past year, outperforming both NIFTY and Nifty Pharma index. It has gained 13.46% in the last month, with trading volume at 3.53 lakh shares today.Divis Laboratories Secures Long-Term Pharma Agreement - 24 May, 2025
Divis Laboratories has entered a long-term manufacturing and supply agreement with a global pharma company, expecting significant revenue contributions. The company plans to invest ₹650-750 crore for capacity expansion, funded through phased customer advances.Divis Laboratories Maintains Accumulate Rating with Target Price - 23 May, 2025
Devan Choksey recommends accumulating Divis Laboratories with a target price of INR 7,518. Despite lower revenue growth and other income, the medium to long-term outlook remains positive due to a robust order pipeline and expected margin expansion.Divis Laboratories Breaks Out of Consolidation Range - 22 May, 2025
Divis Laboratories has broken out of a consolidation range of ₹5,350 to ₹6,250 after seven months, trading near record highs. The positive momentum in the pharma sector suggests potential for continued gains, encouraging traders to consider long positions.Divis Laboratories Sees Stock Rise Amid Analyst Rating Change - 21 May, 2025
Divis Laboratories shares increased by 2.07% to Rs 6,586, showcasing strong financial metrics. However, ICICI Securities downgraded the stock to REDUCE, raising the target price to Rs 5,610.Divis Laboratories Shows Bullish Momentum and Target Prices - 20 May, 2025
Divis Laboratories has broken a key resistance level, indicating bullish momentum, with target prices of ₹7,150 and ₹7,300. Jefferies maintains a hold rating at ₹6,200 due to patent challenges and high valuation concerns.Divis Labs Reports Strong Q4 Earnings and Dividend - 17 May, 2025
Divis Laboratories announced a 23% YoY increase in Q4 PAT to Rs 662 crore, with revenue rising 12%. The board recommended a Rs 30 dividend for FY25.Divis Laboratories Shares Rise Amid Positive Sentiment - 14 May, 2025
Divis Laboratories shares increased by 2.02% to Rs 6199.00, reflecting strong investor activity. The company's consistent financial performance supports a bullish sentiment in the market.Divis Labs Shares Rise with Market Rally - 13 May, 2025
Divis Laboratories Ltd shares rose as part of a broader rally in pharmaceutical stocks, driven by investor confidence in minimal impact from US policy changes.
Insights on Divis Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 2.40K Cr → 2.67K Cr (in ₹), with an average increase of 10.1% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 11.89% to 12.83% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, DIVISLAB stock has moved up by 13.8%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 17.99% to 18.01% in Mar 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, 430.0 Cr → 662.0 Cr (in ₹), with an average increase of 13.4% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, DIVISLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 42.0%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 51.89% of holdings in Mar 2025 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 9.59% to 9.39% in Mar 2025 quarter
About Divis' Laboratories
Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.
Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.
Revenue: ₹2,585.00Cr as on March 2025 (Q4 FY25)
Net Profit: ₹662.00Cr as on March 2025 (Q4 FY25)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
| Organisation | Divis Laboratories Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | Ramesh B V Nimmagadda |
| E-voting on shares | Click here to vote |
Mutual Funds that own Divis' Laboratories
Check out the Mutual Funds with significant holdings in Divis' Laboratories.
FAQs
What is Divis' Laboratories share price today?
Divis' Laboratories share price today stands at ₹6667, Open: ₹6700, Previous Close: ₹6725, High: ₹6720.5, Low: ₹6611, 52 Week High: ₹6766, 52 Week Low: ₹4395.3.
What is today's traded volume of Divis' Laboratories?
Today's traded volume of Divis' Laboratories is 4.31L. Which means that 4.31L shares of Divis' Laboratories were bought and sold on the stock market during today's trading session.
What is Divis' Laboratories's market cap today?
Today's market capitalisation of Divis' Laboratories is ₹1,76,987.90 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Divis' Laboratories?
Divis' Laboratories’s 52 week high is ₹6766 and 52 week low is ₹4395.3. The current share price of Divis' Laboratories is ₹6667, which is -1.46% down from its 52 week high and 51.68% up from its 52 week low.